article thumbnail

Five Questions With a16z’s Vijay Pande on AI and Making New Drugs

Xconomy

Those tools—artificial intelligence and machine learning, respectively—have been around for decades, but in recent years have become faster and cheaper, accelerating their use by those in the business of discovering and developing new drugs. Andreessen Horowitz, also.

article thumbnail

Ada-AI Seeks to Build a Diverse Artificial Intelligence Community

Xconomy

Artificial intelligence innovation has become part of our everyday lives—retailers use it to tailor the product recommendations they make; biotech companies hope it can create customized medicine. But its shortcomings, born of human biases, are becoming apparent as well.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nervana’s $400M+ Buyout Reflects Key Tech Trend in Machine Learning

Xconomy

On the day after Intel announced its acquisition of San Diego machine learning startup Nervana Systems, investor Steve Jurvetson told me he was feeling a sense of satisfaction about a call he made three years ago, and how it has been playing out. In the 2-1/2 years since it was founded, Nervana raised roughly $25 million.

article thumbnail

Saxena: More Than a Tool, A.I. Must Be Used With Society in Mind

Xconomy

[ Updated 12/27/18, 9:54 am ] Manoj Saxena is bullish on artificial intelligence. startup CognitiveScale and managing director of The Entrepreneur Fund , which makes investments in early-stage machine learning companies, Saxena believes A.I. As chairman of Austin, TX-based A.I.

article thumbnail

San Diego Roundup: Qualcomm, Philter, Stella Labs, VC Funding & More

Xconomy

AON Devices, headed by former Qualcomm engineer Mouna El Khatib, is developing semiconductors that use ultra-low-power artificial intelligence algorithms for voice and audio recognition by battery-powered applications. Qualcomm Ventures invited 10 artificial intelligence, Internet of Things, virtual reality, and.

article thumbnail

AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund

Xconomy

AstraZeneca says it will establish centers for drug research and artificial intelligence development in China. The pharmaceutical giant has also set up a $1 billion fund to foster biotech innovation in that country.

article thumbnail

Whiskey Coffee, Immigration, AI: MassChallenge Austin 2019 Startups

Xconomy

They’re startups that are developing products in a wide range of sectors, including life sciences, agriculture, and artificial intelligence. Many of the founders are women: 56 percent, according to MassChallenge , which is funded by a wide variety of private and public groups.